Your AI Vendor's Data Problem Is Your Compliance Problem
Fabrizio Maniglio
February 27, 2026
The AI industry’s data rights mess will get sorted out.
Big AI organizations will pay settlements. We’re already seeing it with authors, publishers, content platforms. Lawyers will do their job.
That’s not the risk you should be focused on.
The Data That Actually Matters
If you work in life sciences, the IP debate at the foundation model level is almost a distraction. The data that matters isn’t what went into building Claude or GPT.
It’s yours.
Your clinical data. Your regulatory submissions. Your R&D pipeline. The proprietary knowledge that took decades and hundreds of millions to build.
Once that goes into a vendor’s system, it’s out. You can’t litigate your way to getting it back. No settlement will make you whole. The damage is structural.
This Isn’t a Reason to Avoid AI
This is a reason to be extremely deliberate about which vendor gets access to what, and when.
I keep having this conversation with leaders across the industry. The question isn’t whether to adopt AI. It’s whether you’ve done the work before you commit.
Treat AI Vendors Like Critical Suppliers
The approach should be familiar to anyone in regulated industries: treat AI vendor selection like you treat any critical supplier.
- Validate their systems
- Audit their data practices
- Understand exactly where your data goes and who can see it
- Map the data flows before you sign the contract, not after
This is supplier qualification applied to a new category of supplier. The principles aren’t new. The urgency is.
The Competitive Divide
The life sciences organizations that get this right now will have a durable competitive advantage. They’ll adopt AI faster and more confidently because they did the due diligence up front.
The ones that don’t will spend years trying to recover something that can’t be recovered. Proprietary knowledge, once exposed, doesn’t come back. There’s no undo button for data leakage.
The AI adoption decision isn’t just a technology decision or a compliance decision. It’s a strategic one. And the organizations making it deliberately, with clear eyes about where their data goes, are the ones that will lead.
Fabrizio Maniglio
Keynote speaker & thought leader helping life sciences organizations navigate AI, quality, and the humans caught between the two.